pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

20,113 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: approval×type: recall×clear all
type
  • approval18,987
  • phase readout7,208
  • device 510k5,000
  • grant4,728
  • 8k filing3,603
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings585
  • therapy area

    no tagged catalysts yet

    Week of Dec 8, 2025

    47
    ›Dec 10, 2025recall263d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Wecare Calasoothe, Net wt. 4 oz (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, NDC 67777-234-04. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall263d agoBreckenridge Pharmaceutical, Inc. recall (Cls II)Breckenridge Pharmaceutical Inc

    Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Manufactured for : Quallient Pharmaceuticals Health, LLC, Grand Cayman, Cayman Islands, NDC 82009-032-10. — Reason: CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall263d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Dynashield, 4 oz cream (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10852, USA, Made in India, NDC 67777-407-03. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall263d agoTeva Pharmaceuticals USA, Inc recall (Cls III)Terns Pharmaceuticals, Inc.

    Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Manufactured by: Actavis Laboratories, Inc, Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-3216-30. Packet label: Testosterone Gel 1%, contains 2.5 grams, For topical use only, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054,NDC: 0591-3216-17. — Reason: Defective Container - A defect in the side-seal which allows leakage of product. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall263d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Nivagen, Zinc Oxide Ointment USP, Zinc Oxide 20 %, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, Made in India, NDC 75834-170-02. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall263d agoCipla Limited recall (Cls II)Cipla Ltd

    Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule Lifesciences PVT. Ltd. India. Mfd. for: Cipla USA, Inc. Warren, NJ 07059. Vial NDC# 69097-708-31; Carton NDC 69097-708-96 — Reason: Failed Stability Specifications: Observed OOS results: eg results for colour index — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall263d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Globe Clotrimazole Cream, USP, 1 %, Net Wt. 1 oz (28.4g), Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301 USA, Made in India, NDC 69396-087-01. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall263d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Lanashield Skin Barrier, 4 oz. (113 g), Manfuactured for: Dynarex Corporation, 10 Gleshaw Street, Orangeburg, NY 10962 USA, Made in India, UPC 616784126319. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall263d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Nivagen, Zinc Oxide Ointment, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA Made in India, NDC 75834-170-01. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall263d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Globe Clotrimazole Cream USP, 1 % Antifungal Cream, Net Wt., 5 oz. (142 g, Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, USA, NDC 69396-087-55. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall263d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Dynagel, Moisturizing Wound Hydrogel, Net Wt. 3oz (84.7 g), Manufactured for: Dynarex Corporation, 16 Glenshaw Street, Orangeburg, NY 10962, UPC 61784128016. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall263d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    WeCare, Zinc Oxide Ointment, Net Wt. 15 oz/425 g, Manuactured for: Dynarex Corporation, 11 Dynarex Drive, Middletown, NY 10941, Made in India, NDC 67777-223-05. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2025approval262d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: ACTAVIS LABS FL INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 11, 2025approval262d agoTRAMADOL HYDROCHLORIDE — FDA approvalTrigen Laboratories Inc

    Sponsor: TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 11, 2025approval262d agoACETAMINOPHEN AND IBUPROFEN (ACETAMINOPHEN) — FDA approvalPERRIGO Co plc

    Sponsor: LNK INTL INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 11, 2025approval262d agoDEFERIPRONE — FDA approvalSenores Pharmaceuticals Inc

    Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 11, 2025approval262d agoBLUJEPA (GEPOTIDACIN MESYLATE) — FDA approvalgepotidacin mesylate

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →gepotidacin mesylate →fda approvals ↗
    ›Dec 11, 2025approval262d agoCABERGOLINE — FDA approvalCABERGOLINE

    Sponsor: INGENUS PHARMS LLC. Form: TABLET. Route: ORAL

    full page →CABERGOLINE →fda approvals ↗
    ›Dec 11, 2025approval262d agoMEROPENEM — FDA approvalHQ Speciality Pharma

    Sponsor: BROOKS STERISCIENCE. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 11, 2025approval262d agoXTANDI (ENZALUTAMIDE) — FDA approvalenzalutamide

    Sponsor: ASTELLAS. Form: TABLET. Route: ORAL

    full page →enzalutamide →fda approvals ↗
    ›Dec 11, 2025approval262d agoXTANDI (ENZALUTAMIDE) — FDA approvalenzalutamide

    Sponsor: ASTELLAS. Form: CAPSULE. Route: ORAL

    full page →enzalutamide →fda approvals ↗
    ›Dec 11, 2025approval262d agoORLADEYO (BEROTRALSTAT DIHYDROCHLORIDE) — FDA approvalberotralstat hydrochloride

    Sponsor: BIOCRYST. Form: PELLETS. Route: ORAL

    full page →berotralstat hydrochloride →fda approvals ↗
    ›Dec 11, 2025approval262d agoNOREPINEPHRINE BITARTRATE — FDA approvalNOREPINEPHRINE BITARTRATE

    Sponsor: MSN. Form: INJECTABLE. Route: INJECTION

    full page →NOREPINEPHRINE BITARTRATE →fda approvals ↗
    ›Dec 11, 2025approval262d agoUPLIZNA (INEBILIZUMAB-CDON) — FDA approvalHorizon Therapeutics USA Inc

    Sponsor: VIELA BIO. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 11, 2025approval262d agoDAYBUE STIX (TROFINETIDE) — FDA approvaltrofinetide

    Sponsor: ACADIA PHARMS INC. Form: FOR SOLUTION. Route: ORAL

    full page →trofinetide →fda approvals ↗
    ›Dec 11, 2025approval262d agoLOPINAVIR AND RITONAVIR (LOPINAVIR) — FDA approvalLOPINAVIR AND RITONAVIR

    Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

    full page →LOPINAVIR AND RITONAVIR →fda approvals ↗
    ›Dec 12, 2025approval261d agoTRAMADOL HYDROCHLORIDE — FDA approvalTrigen Laboratories Inc

    Sponsor: SUN PHARM. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 12, 2025approval261d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: ALKEM LABS LTD. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 12, 2025approval261d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

    Sponsor: ACTAVIS ELIZABETH. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →tramadol hydrochloride ER →fda approvals ↗
    ›Dec 12, 2025approval261d agoTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: MICRO LABS LTD INDIA. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 12, 2025approval261d agoADBRY (TRALOKINUMAB) — FDA approvaltralokinumab

    Sponsor: LEO PHARMA AS. Form: INJECTABLE. Route: INJECTION

    full page →tralokinumab →fda approvals ↗
    ›Dec 12, 2025approval261d agoROMVIMZA (VIMSELTINIB) — FDA approvalDeciphera Pharmaceuticals Inc

    Sponsor: DECIPHERA PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 12, 2025approval261d agoSTEQEYMA (USTEKINUMAB-STBA) — FDA approvalSTEQEYMA

    Sponsor: CELLTRION, INC.. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →STEQEYMA →fda approvals ↗
    ›Dec 12, 2025approval261d agoNUZOLVENCE (ZOLIFLODACIN) — FDA approvalEntasis Therapeutics Holdings Inc

    Sponsor: ENTASIS THERAP. Form: FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 12, 2025approval261d agoOCTREOTIDE ACETATE — FDA approvalChiasma Inc

    Sponsor: MYLAN LABS LTD. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 12, 2025approval261d agoTERIPARATIDE — FDA approvalEB-613

    Sponsor: AMPHASTAR PHARMS INC. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →EB-613 →fda approvals ↗
    ›Dec 12, 2025approval261d agoNISOLDIPINE — FDA approvalPrasco LLC

    Sponsor: AMTA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 12, 2025approval261d agoLEROCHOL (LERODALCIBEP-LIGA) — FDA approvallerodalcibep

    Sponsor: LIB THERAPEUTICS, INC.. Form: INJECTABLE. Route: INJECTION

    full page →lerodalcibep →fda approvals ↗
    ›Dec 12, 2025approval261d agoDEPO-SUBQ PROVERA 104 (MEDROXYPROGESTERONE ACETATE) — FDA approvalmedroxyprogesterone acetate

    Sponsor: PFIZER. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →medroxyprogesterone acetate →fda approvals ↗
    ›Dec 12, 2025approval261d agoILUMYA (TILDRAKIZUMAB-ASMN) — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: SUN PHARMA GLOBAL. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 12, 2025approval261d agoDEFLAZACORT — FDA approvalDEFLAZACORT

    Sponsor: AMNEAL. Form: TABLET. Route: ORAL

    full page →DEFLAZACORT →fda approvals ↗
    ›Dec 12, 2025approval261d agoCARDAMYST (ETRIPAMIL) — FDA approvalMilestone Pharmaceuticals Inc.

    Sponsor: MILESTONE PHARMS USA. Form: SPRAY. Route: NASAL

    full page →fda approvals ↗
    ›Dec 12, 2025approval261d agoDEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) — FDA approvalmedroxyprogesterone acetate

    Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

    full page →medroxyprogesterone acetate →fda approvals ↗
    ›Dec 12, 2025approval261d agoAKEEGA (ABIRATERONE ACETATE) — FDA approval(abiraterone acetate + niraparib)

    Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL

    full page →(abiraterone acetate + niraparib) →fda approvals ↗
    ›Dec 12, 2025approval261d agoROLVEDON (EFLAPEGRASTIM-XNST) — FDA approvalSpectrum Pharmaceuticals Inc

    Sponsor: SPECTRUM PHARMS. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Dec 13, 2025approval260d agoADDYI (FLIBANSERIN) — FDA approvalSprout2 Inc

    Sponsor: SPROUT PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 14, 2025approval259d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: WES PHARMA INC. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗

    Week of Dec 15, 2025

    3
    ›Dec 15, 2025approval258d agoLEQEMBI (LECANEMAB-IRMB) — FDA approvallecanemab

    Sponsor: EISAI INC. Form: INJECTABLE. Route: INJECTION

    full page →lecanemab →fda approvals ↗
    ›Dec 15, 2025approval
    ← prev
    page 364 of 403
    next →
    258d ago
    LEQEMBI (LECANEMAB-IRMB) — FDA approvallecanemab

    Sponsor: EISAI INC. Form: INJECTABLE. Route: INJECTION

    full page →lecanemab →fda approvals ↗
    ›Dec 15, 2025approval258d agoPROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE (CODEINE PHOSPHATE) — FDA approvalCosette Pharmaceuticals Inc

    Sponsor: PHARMOBEDIENT. Form: SYRUP. Route: ORAL

    full page →fda approvals ↗
    $BCRX9.8200-0.51%
    $AMRX17.54-2.61%
    $PFE27.96-0.21%
    $ACAD29.11-2.09%
    $AMPH21.88-0.64%
    $AMRX17.54-2.61%
    $IGC0.2670+0.41%
    $PRGO14.48+2.84%
    $TGTX55.72+1.25%
    $TERN52.95-0.03%
    $PFE27.96-0.21%
    $IGC0.2670+0.41%
    $MIST